Lipocine Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
21.26 M |
Public Float |
20.02 M |
Lipocine Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.55 |
Market Cap |
$47.43 M |
Shares Outstanding |
24.58 M |
Public Float |
20.02 M |
Address |
675 Arapeen Drive Salt Lake City Utah 84108 United States |
Employees | - |
Website | http://www.lipocine.com |
Updated | 07/08/2019 |
Lipocine, Inc. is a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded on July 24, 2013 and is headquartered in Salt Lake City, UT. |